Carpal tunnel syndrome (CTS) is median nerve compression in a narrow bony-ligamentous canal at the wrist. It is the most common tunnel neuropathy affecting up to 5% of the population, predominantly women aged 40–60. The hallmark symptom is nighttime finger numbness and tingling. Treatment in Germany includes precise electrodiagnostics, innovative MIBRAR® therapy for nerve regeneration, and when necessary — minimally invasive endoscopic decompression.
The carpal tunnel is formed by carpal bones (floor and walls) and the transverse carpal ligament (roof). Through it pass the median nerve and 9 flexor tendons. Any decrease in tunnel volume or increase in content volume compresses the nerve. The median nerve provides sensation to the thumb, index, middle, and half of the ring finger, plus motor innervation to thenar muscles. Prolonged compression causes demyelination, then axonal damage — muscle atrophy and irreversible sensory loss.
Professional overload from prolonged computer work (mouse, keyboard), vibrating tool use, and assembly line work is the leading cause. Anatomically narrow tunnels (more common in women), flexor tenosynovitis from rheumatoid arthritis or tendinopathy, hormonal factors (pregnancy, menopause, hypothyroidism), diabetes (diabetic neuropathy makes the nerve more vulnerable), wrist fractures (especially distal radius), space-occupying lesions (ganglions, lipomas), and obesity all contribute.
Nighttime numbness is the earliest and most characteristic symptom — "I wake up with numb fingers, shake my hand — it passes." Tingling ("pins and needles") affects the thumb, index, and middle fingers. Pain in the wrist and fingers may radiate to the forearm and shoulder. Clumsiness leads to dropping objects and difficulty with fine motor tasks (buttoning). Grip weakness develops in later stages. Thenar atrophy — flattening of muscles at the thumb base — is an irreversible sign requiring urgent surgery.
| Stage | Symptoms | Treatment |
|---|---|---|
| Mild | Nighttime numbness, tingling. Normal during day | Splint, MIBRAR®, observation |
| Moderate | Constant numbness, daytime symptoms, clumsiness | MIBRAR® or surgery |
| Severe | Persistent numbness, weakness, thenar atrophy | Surgical decompression (don't delay!) |
Clinical tests include Tinel's (tapping over the tunnel → "electric shock" in fingers), Phalen's (maximum wrist flexion 60 sec → numbness), and Durkan's (direct tunnel pressure). EMG/nerve conduction studies (NCS) are the gold standard — measuring median nerve conduction velocity at the wrist. Slowing confirms the diagnosis and determines damage degree (demyelination or axonopathy). Wrist ultrasound visualizes the thickened nerve (cross-sectional area >10 mm² = pathological), ganglions, and tenosynovitis. MRI is used in complex cases. Laboratory tests include TSH (hypothyroidism), glucose (diabetes), and rheumatoid factor.
Effective at the mild stage. A night splint (orthosis) holds the wrist in neutral position during sleep, reducing tunnel pressure — the first-line therapy. Ergonomics involves an ergonomic mouse, wrist rest, and computer work breaks. NSAIDs provide brief flare relief. Carpal tunnel corticosteroid injection gives rapid effect in 70–80% but is temporary (3–6 months) and limited to 1–2 injections. Underlying disease treatment corrects hypothyroidism and diabetes compensation.
Carpal tunnel syndrome (Karpaltunnelsyndrom) is included in the indications for MIBRAR® technology, offering a cortisone and surgery alternative for mild-moderate stages. ARC contains neurotrophic factors stimulating damaged nerve remyelination. The anti-inflammatory effect reduces tenosynovial swelling in the tunnel without cortisone — which can damage the nerve during injection! Tendon sheath regeneration reduces tenosynovitis (the main compression cause). Neuroregeneration through mesenchymal stem cells supports nerve fiber recovery — per Prof. Babayan's book, MIBRAR® is applied for central and peripheral nervous system structure regeneration.
The procedure delivers ARC precisely into the carpal tunnel under Sono Control Arm™ guidance (0.1 mm precision) with real-time nerve and tendon visualization — excluding nerve injury during injection. Outpatient, without anesthesia.
Indicated for moderate-severe stages, thenar atrophy, conservative failure over 3–6 months, and axonal damage on EMG. Endoscopic decompression (Chow or Agee technique) divides the transverse carpal ligament through a 5 mm puncture using an endoscope — minimal trauma, rapid recovery, return to work in 1–2 weeks. Open decompression uses a 2–3 cm palmar incision — the classic method with full nerve visualization, return to work in 3–4 weeks. Mini-open uses a 1.5 cm incision as an intermediate option. Surgery is performed under local anesthesia, outpatient, in 10–20 minutes with 90–95% effectiveness. Night symptom improvement occurs the very first night after surgery.
| Service | Price, € | Note |
|---|---|---|
| Diagnostics (EMG + ultrasound + exam) | 1,500–3,000 | 1 day |
| MIBRAR® therapy | on request | outpatient |
| Endoscopic decompression | 3,000–5,000 | outpatient |
All treatment prices in Germany.
Germany offers precise electrodiagnostics (EMG/NCS) for stage determination, MIBRAR® therapy for neuroregeneration and cortisone-free inflammation elimination, endoscopic decompression through a 5 mm puncture with minimal trauma, local anesthesia outpatient surgery, rapid recovery (return to work in 1–2 weeks), and multilingual assistance at German clinics. Don't ignore nighttime finger numbness — early treatment ensures fuller nerve recovery. Contact us for treatment planning.
Or send us a message:
